Welcome to CDC Stacks | Mass Spectrometric Identification and Differentiation of Botulinum Neurotoxins through Toxin Proteomics - 33993 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Mass Spectrometric Identification and Differentiation of Botulinum Neurotoxins through Toxin Proteomics
Filetype[PDF - 102.86 KB]


Details:
  • Pubmed ID:
    26316676
  • Pubmed Central ID:
    PMC4549225
  • Description:
    Botulinum neurotoxins (BoNTs) cause the disease botulism, which can be lethal if untreated. There are seven known serotypes of BoNT, A-G, defined by their response to antisera. Many serotypes are distinguished into differing subtypes based on amino acid sequence and immunogenic properties, and some subtypes are further differentiated into toxin variants. Toxin characterization is important as different types of BoNT can respond differently to medical countermeasures for botulism, and characterization of the toxin can aid in epidemiologic and forensic investigations. Proteomic techniques have been established to determine the serotype, subtype, or toxin variant of BoNT. These techniques involve digestion of the toxin into peptides, tandem mass spectrometric (MS/MS) analysis of the peptides, and database searching to identify the BoNT protein. These techniques demonstrate the capability to detect BoNT and its neurotoxin-associated proteins, and differentiate the toxin from other toxins which are up to 99.9% identical in some cases. This differentiation can be accomplished from toxins present in a complex matrix such as stool, food, or bacterial cultures and no DNA is required.

  • Document Type:
  • Collection(s):
  • Funding:
    SSK7/Intramural CDC HHS/United States
No Related Documents.
You May Also Like: